CPL SACHSE

About CPL SACHSE

CPL Sachse manufactures active pharmaceutical ingredients (small molecules) under cGMP for (pre-) clinical development and, if necessary, subsequent commercialization on a pilot plant scale (≤ 50 kg). The company has been successfully inspected several times by the FDA. We develop and validate the analytical methods needed to test APIs and drug products and offer regulatory services.

Certifications
  • DE
  • 2023
    On CPHI since
  • 2
    Certificates
  • 25 - 49
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Manufacturer/Innovator
Primary activities
API Producer
Chemical Development
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Regulatory Affairs
Contact info

Products from CPL SACHSE (3)

  • Clenbuterol hydrochloride

    Product Clenbuterol hydrochloride

    Our production follows cGMP and is in accordance with the EU-GMP-Guideline Part II (ICH Q7). We are regularly inspected by the responsible local authority which issues us with drug substance-specific GMP certificates. We are currently manu...
  • Detomidine hydrochloride

    Product Detomidine hydrochloride

    Our production follows cGMP and is in accordance with the EU-GMP-Guideline Part II (ICH Q7). We are regularly inspected by the responsible local authority which issues us with drug substance-specific GMP certificates. We are currently manu...
  • Medetomidine hydrochloride

    Product Medetomidine hydrochloride

    Our production follows cGMP and is in accordance with the EU-GMP-Guideline Part II (ICH Q7). We are regularly inspected by the responsible local authority which issues us with drug substance-specific GMP certificates. We are currently manu...